An interventional study of HIIE - Normoxia and HIIE - Hypoxia in Obesity & Overweight, Energy Expenditure and Substrate Oxidation, sponsored by Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques. Completed at 1 site in France. Open to participants aged 50 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-11.
Sponsored by Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 475 studies in Obesity with a site in France — 111 open to participants now, 127 under way, 25 of them phase 3. Obesity · France.
Among the 475 studies in Obesity with a site in France, this one is the 319th largest by enrollment of the 354 interventional ones that give a count, is one of 23 that started in 2024, is one of 258 with no phase, and was the 470th registered.
11,529 studies on the registry are indexed under Obesity; 2,035 are open to participants now.
Browse Obesity studies →111 of the 475 studies in Obesity with a site in France are open now. Recruiting first, the newest first:
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques · Sites in France
Ages 50–75
AstraZeneca · Sites in France, United States, Argentina and 13 more countries
Ages 18+
Novo Nordisk A/S · Sites in France, United States, Belgium and 7 more countries
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 18–75
Universite du Littoral Cote d'Opale · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 1,336 Obesity studies recruiting now, 377 (28%) set no upper age limit and 856 (64%) stop at 75 or younger; 166 take children under 18; 488 take healthy volunteers.
This study: 50 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
475 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 21 · Phase 3 61 · Phase 4 14
First in 2001; this study’s year is marked. 23 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 18 is below the median of 67 across 9,010 interventional studies indexed under Obesity.
Median enrollment 80 across the 354 interventional studies, 133 across the 121 observational. Of the 295 that completed or were terminated, 16 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
76 of 475 have an industry lead sponsor. The 10 most frequent:
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques is the lead sponsor of 8 studies on the registry; 2 are open to participants now.
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques has 5 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
30 of the studies in Obesity with a site in France that are under way reach primary completion within a year, 8 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06914895Phase 3Eli Lilly and CompanyA Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight | 2026-11 |
| NCT06962280Phase 3Eli Lilly and CompanyA Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight | 2026-11 |
| NCT03516968Phase 3Hospices Civils de LyonMonthly Boluses Versus Daily Doses for Correcting Blood Vitamin D Deficit in Obese Children and Adolescents | 2027-03 |
| NCT07220642Phase 3Novo Nordisk A/SWeight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide | 2027-05-11 |
| NCT07225686Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy | 2027-08-20 |
Add all 30 to your calendar (.ics) → With an account.
Among the 475 studies in Obesity with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Obesity management involves lifestyle and dietary measures that include appropriate nutrition and increased physical activity (PA). Among the various PA options available, HIIT (High-Intensity Interval Training) workouts are now recognized as fun and effective programs for promoting fat loss. To date, in overweight or obese individuals, only two studies mention the benefits of HIIT performed under hypoxia for modulating body composition, and more specifically, reducing the amount of adipose tissue. These studies hypothesize an increased energy expenditure under hypoxia associated with a transient loss of appetite. In order, to further investigate the adaptations following HIIT under hypoxia versus normoxia, we propose to compare, in acute conditions, two HIIT sessions (simulated hypoxia-normobaric vs. normoxia) in overweight or obese subjects. The objective of this assessment is to compare, during exercise and recovery (+2h), oxygen consumption, corresponding energy expenditure, and carbohydrate and lipid utilization in hypoxic versus normoxic conditions. Given the potential influence of hypoxia on appetite, spontaneous food intake and energy expenditure post-24h will also be measured. Finally, since pleasure and perceived exertion are key parameters in adherence to an adapted physical activity (APA) program, these two concepts will also be evaluated through the subjects' experiences.
Obesity management involves lifestyle and dietary measures that include appropriate nutrition and increased physical activity (PA). Among the various PA options available, High-intensity interval training (HIIT) is now recognized as a well-tolerated, safe, and effective exercise modality for improving body composition. In 2016, our pioneering study demonstrated that HIIT is more effective than moderate-intensity continuous training (MICT) in inducing abdominal fat loss in postmenopausal women. A subsequent meta-analysis, conducted by our team in 2018 and encompassing 39 articles involving 617 participants, confirmed the significant effects of HIIT on reducing total and abdominal fat mass in overweight or obese individuals More recently, our work has shown significant results from HIIT + resistance training or HIIT cycling vs. running on improving body composition, and more specifically on reducing abdominal and visceral fat mass, in overweight or obese subjects.
With a focus on performance, HIIT has been combined with simulated hypoxia to maximize training adaptations, particularly to improve cardiovascular, respiratory, circulatory, hematological, and metabolic capacities at the muscular level. Live Low Train High (LLTH) allows athletes to maintain normoxia while being exposed to acute periods of hypoxia during training via hypoxic chambers (simulated altitude). More recently, research has explored the effects of HIIT under hypoxic conditions in patients with metabolic disorders and/or physical deconditioning, focusing primarily on cardiovascular and ventilatory adaptations. To date, in overweight or obese individuals, only three studies investigated the benefit of HIIT under simulated hypoxia for modulating body composition, and more specifically for reducing total or abdominal fat. These studies generally hypothesize a higher energy expenditure during hypoxia, associated with a transient loss of appetite that may be linked to hormonal disturbances, central nervous system adaptability, or metabolic flexibility altering hunger and satiety signals.
In parallel with these hypotheses, hypoxia stimulates HIF-1 production, thus promoting a shift from oxidative metabolism to glycolysis. At the same external mechanical load, the increased use of carbohydrates via glycolysis, combined with increased cardiovascular stress, should promote, during the recovery phase, greater oxygen consumption and lipid oxidation following a hypoxic session. To date, no study has yet evaluated these hypotheses by comparing these parameters following two acute HIIT sessions performed under normoxia or hypoxia.
The aim is to compare the influence of these two sessions on oxygen consumption, the corresponding energy expenditure, and carbohydrate and lipid utilization during recovery (+2h). Given the potential influence of hypoxia on appetite, food intake and spontaneous energy expenditure post-24h will also be measured. Finally, since enjoyment and perceived exertion are crucial parameters for adherence to an adapted physical activity (APA) program, these two concepts will also be assessed through the participants' experiences.
The authors propose the following hypotheses:
Main hypothesis:
Lipid oxidation (g/min) during recovery (+2h) will be higher post-hypoxic session.
Secondary hypotheses:
4/ Energy intake from the post-exercise meal may be lower post-hypoxic condition.
5/ The effort will be perceived as slightly more difficult in hypoxia due to increased cardiovascular demand.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- overweight or obesity ( between 25 kg/m2 and 35 kg/m2)
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIIE in normoxia
Other: HIIE - Normoxia
HIIE in hypoxia
Other: HIIE - Hypoxia
Cycling HIIE in Normoxia: 60 x \[8 seconds at a power equivalent to 80-85% of HRmax followed by 12 seconds of active recovery at a power equivalent to 40% of HRmax\]
Cycling HIIE in Hypoxia (FiO2: 15%): 60 x \[8 seconds at a power equivalent to 80-85% of HRmax followed by 12 seconds of active recovery at a power equivalent to 40% of HRmax\]
Lipid oxidation after the exercise session (nromoxia and hypoxia).
Determination of lipid and carbohydrate oxidation after the exercise (HIIE normoxia and hypoxia). Lipid aoxidation is measured from oxygen and carbon dioxide consumption (Metamax 3D Cortex).
Time frame: Measurement during two hours after the end of the exercise
Oxygen consumption during the recovery period
Determination of oxygen consumption 2 hours after the exercise session (HIIE normoxia and hypoxia). Determination from Metamax (3D Cortex).
Time frame: Two hours after the end of the exercise
Energy intakes 24 hours after the exercise
Evaluation of energy intakes after the exercise session (HIIE normoxia and HIIE hypoxia) during 24 hours (from questionnaires)
Time frame: 24 hours post exercise
Appetite
Feelings of appetite are measured using a visual appetite scale immediately before and after exercise (+0 min, +60 min, and +120 min).
Time frame: Before exercise and after exercise (+0 min, +60 min, and +120 min).
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Nov 2024 to primary completion in Sep 2026, 22 months.
Of 3,683 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 22 months is close to that.
Counting every sponsor, half of 3,846 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques